STATIN-FIBRATE REPORT: Focus on Safety

Jun 26, 2001 · The relative risk reduction for combined cardiac events (nonfatal MI, death from coronary causes or stroke) with gemfibrozil was 24% compared to placebo (95% CI 11-36, p ................
................